Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-07-001236
Filing Date
2007-02-13
Accepted
2007-02-13 17:28:07
Documents
7
Period of Report
2006-10-31

Document Format Files

Seq Description Document Type Size
1 c46717_10-k.txt 10-K 284287
2 c46717_ex3-2a.txt EX-3.2(A) 4206
3 c46717_ex21.txt EX-21 602
4 c46717_ex31-1.txt EX-31.1 3293
5 c46717_ex31-2.txt EX-31.2 3251
6 c46717_ex32-1.txt EX-32.1 1574
7 c46717_ex32-2.txt EX-32.2 1582
  Complete submission text file 0000930413-07-001236.txt   300467
Mailing Address 2425 E CAMELBACK ROAD SUITE 650 PHOENIX AZ 85016
Business Address 2425 E CAMELBACK RD STE 650 PHOENIX AZ 85016 6025080112
Synovics Pharmaceuticals (Filer) CIK: 0001030839 (see all company filings)

EIN.: 860760991 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 000-22011 | Film No.: 07611806
SIC: 2833 Medicinal Chemicals & Botanical Products